GRANTS
- GRANTA prospective randomized basket trial evaluating the clinical utility of plasma-based microbial cell-free metagenomic sequencing for diagnosis and management of suspected infections in adult immunocompromised outpatientsKarius30 Jun 2026 - 29 Jun 2031
- GRANTMedical Scientist Training Program at the University of FloridaNational Institute of Health Nigms3 Jun 2026 - 30 Jun 2031
- GRANTRapid Ex Vivo Gene Mediated Preconditioning of Human Liver and Kidney Grafts Using Lipid Nanoparticle Delivered mRNA During Machine PerfusionAmerican Society of Transplant Surgeons13 May 2026 - 30 Jun 2028
- GRANTLeveraging Renasight Genetic Analysis to Predict Kidney Outcomes in Liver Transplant Recipients with Baseline Kidney DysfunctionNatera12 Feb 2026 - 11 Feb 2031
- GRANTMethylation Evaluation as a Surrogate for Recurrence Risk in Hepatocellular CarcinomaAstrazeneca Pharm29 Jan 2026 - 30 Nov 2027
- GRANTEFFECT OF HEPARIN ADMINISTRATION ON CTDNA KINETICSBilliontoone4 Dec 2025 - 3 Dec 2026
- GRANTCellVaxCellvax Therapeutics12 Sep 2025 - 11 Sep 2026
- GRANTMentoring Patient-Oriented Research in Immune Response in TransplantationNational Institute of Health Niaid9 Sep 2025 - 31 Aug 2030
- GRANTMulti-Canter Validation and Biologic Assessment of a Novel Pre-Transplant Biomarker Panel to Predict Liver Transplant Recipient MortalityNational Institute of Health Niddk5 Aug 2025 - 31 Aug 2029
- GRANTEvaluation of Northstar Response v2.0 in a cohort of cholangiocarcinoma patientsBilliontoone7 Mar 2025 - 6 Mar 2026
- GRANTPhase I Study of NP-101 in Patients with Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 TreatmentNovatek Pharmaceuticals6 Feb 2025 - 27 Apr 2026
- GRANTPhase I study of NP-101 in patients with unresectable Hepatocellular Carcinoma (HCC) undergoing Y-90 TreatmentFlorida Department of Health7 Jun 2024 - 7 Dec 2025
- GRANTTargeted RNA-Lipid Particle Aggregates in Pediatric Oncology: A Novel Therapeutic Strategy for Fibrolamellar Hepatocellular CarcinomaHyundai Hope On Wheels4 Jun 2024 - 31 Dec 2026
- GRANTA trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-negative kidney recipients (THINKER-NEXT)National Institute of Health Niddk13 Dec 2023 - 31 Mar 2025
- GRANTA trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-negative kidney recipients (THINKER-NEXT)National Institute of Health Niddk13 Dec 2023 - 31 Mar 2027
- GRANTAD HOC Trial: AD HOC Trial: Artificial Intelligence-Based Drug Dosing in Hepatocellular CarcinomaSun Pharma Global Fze8 Dec 2023 - 13 Jan 2025
- GRANTAD HOC Trial: AD HOC Trial: Artificial Intelligence-Based Drug Dosing in Hepatocellular CarcinomaSun Pharma Global Fze8 Dec 2023 - 8 Dec 2026
- GRANTAD HOC Trial: Artificial Intelligence-Based Drug Dosing in Hepatocellular CarcinomaSun Pharma Global Fze8 Dec 2023 - 9 Dec 2023
- GRANTUsing Transcriptional Assessment of Immune Response to Assess Immunosuppression After Liver TransplantationTransplant Genomics26 May 2023 - 25 May 2028
- GRANTIdentifying Clinical and Molecular Determinants of Health Disparities in Hepatitis C and Hepatitis-C Related Hepatocellular CarcinomaAmerican Society of Transplant Surgeons27 Apr 2023 - 30 Jun 2025
- GRANTImproving the efficacy of human primary hepatocyte transplantation: Implementation of a novel 3D peptide hydrogelAmerican Society of Transplant Phys13 Apr 2023 - 30 Jun 2024
- GRANTModeling the Molecular Pathways of the Hispanic NAFLD/NASH Disparity in Human Precision Cut Liver Slices.American Society of Transplant Phys13 Apr 2023 - 30 Jun 2024
- GRANTBacterial DNA as a Diagnostic Biomarker of Hepatocellular CarcinomaNational Institute of Health Nci14 Feb 2023 - 31 Jan 2023
- GRANTGlobal Utilization And Registry Database for Improved preservAtion of doNor LIVERs (GUARDIAN-LIVER)Paragonix Technologies10 Nov 2022 - 9 Nov 2027
- GRANTCTOAUniversity of Florida26 Jul 2022 - 31 Oct 2024